The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Insulin-like
".
FunFam 3: Insulin
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 20 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Insulin receptor binding GO:0005158
Interacting selectively and non-covalently with the insulin receptor.
|
8 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) P01317 (/IDA) P01322 (/IDA) |
Insulin-like growth factor receptor binding GO:0005159
Interacting selectively and non-covalently with the insulin-like growth factor receptor.
|
8 | A5PJB2 (/ISS) I7CLV3 (/ISS) I7CLV3 (/ISS) L5LRB0 (/ISS) L5LRB0 (/ISS) P01318 (/ISS) Q25C78 (/ISS) Q25C78 (/ISS) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
7 | I3WAC9 (/IPI) I3WAC9 (/IPI) I3WAC9 (/IPI) P01308 (/IPI) P01308 (/IPI) P01308 (/IPI) P01317 (/IPI) |
Protease binding GO:0002020
Interacting selectively and non-covalently with any protease or peptidase.
|
5 | P01308 (/IPI) P01308 (/IPI) P01308 (/IPI) P01322 (/IPI) P01323 (/IPI) |
Protease binding GO:0002020
Interacting selectively and non-covalently with any protease or peptidase.
|
5 | P01325 (/ISO) P01325 (/ISO) P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Insulin receptor binding GO:0005158
Interacting selectively and non-covalently with the insulin receptor.
|
5 | P01325 (/ISO) P01325 (/ISO) P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
5 | P01308 (/IPI) P01308 (/IPI) P01308 (/IPI) P01315 (/IPI) P01317 (/IPI) |
Hormone activity GO:0005179
The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.
|
4 | P01308 (/IMP) P01308 (/IMP) P01308 (/IMP) P01315 (/IMP) |
Insulin receptor binding GO:0005158
Interacting selectively and non-covalently with the insulin receptor.
|
3 | P01308 (/IPI) P01308 (/IPI) P01308 (/IPI) |
Insulin-like growth factor receptor binding GO:0005159
Interacting selectively and non-covalently with the insulin-like growth factor receptor.
|
3 | P01308 (/IPI) P01308 (/IPI) P01308 (/IPI) |
Insulin-like growth factor receptor binding GO:0005159
Interacting selectively and non-covalently with the insulin-like growth factor receptor.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Hormone activity GO:0005179
The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.
|
3 | P01308 (/IC) P01308 (/IC) P01308 (/IC) |
Hormone activity GO:0005179
The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Hormone activity GO:0005179
The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.
|
3 | P01308 (/NAS) P01308 (/NAS) P01308 (/NAS) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Chaperone binding GO:0051087
Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
|
2 | P01325 (/ISO) P01325 (/ISO) |
Insulin-like growth factor receptor binding GO:0005159
Interacting selectively and non-covalently with the insulin-like growth factor receptor.
|
1 | P01315 (/IMP) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
1 | P01323 (/IPI) |
Chaperone binding GO:0051087
Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
|
1 | P01322 (/IPI) |
There are 175 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Insulin receptor signaling pathway GO:0008286
The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.
|
6 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) P01326 (/IDA) P01326 (/IDA) P01326 (/IDA) |
Response to nutrient levels GO:0031667
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.
|
6 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) O73727 (/IDA) O73727 (/IDA) P01317 (/IDA) |
Glucose homeostasis GO:0042593
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
|
6 | P01308 (/IMP) P01308 (/IMP) P01308 (/IMP) P01326 (/IMP) P01326 (/IMP) P01326 (/IMP) |
Response to L-arginine GO:1903576
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a L-arginine stimulus.
|
6 | L5LRB0 (/ISS) L5LRB0 (/ISS) P01315 (/ISS) P01318 (/ISS) Q25C78 (/ISS) Q25C78 (/ISS) |
Negative regulation of protein secretion GO:0050709
Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of a protein from a cell.
|
5 | I7CLV3 (/IDA) I7CLV3 (/IDA) P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Glucose transmembrane transport GO:1904659
The process in which glucose is transported across a membrane.
|
5 | P01325 (/TAS) P01325 (/TAS) P01326 (/TAS) P01326 (/TAS) P01326 (/TAS) |
Feeding behavior GO:0007631
Behavior associated with the intake of food.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Response to heat GO:0009408
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
|
4 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) P01317 (/IDA) |
Positive regulation of insulin secretion GO:0032024
Any process that activates or increases the frequency, rate or extent of the regulated release of insulin.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Response to food GO:0032094
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a food stimulus; food is anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Negative regulation of appetite GO:0032099
Any process that reduces appetite.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Positive regulation of mammary gland epithelial cell proliferation GO:0033601
Any process that activates or increases the rate or extent of mammary gland epithelial cell proliferation.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Estradiol secretion GO:0035938
The regulated release of estradiol into the circulatory system.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
4 | A5PJB2 (/IMP) I7CLV3 (/IMP) I7CLV3 (/IMP) P01317 (/IMP) |
Glucose import in response to insulin stimulus GO:0044381
The directed movement of the hexose monosaccharide glucose into a cell as a result of an insulin stimulus.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Positive regulation of insulin receptor signaling pathway GO:0046628
Any process that increases the frequency, rate or extent of insulin receptor signaling.
|
4 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) P01315 (/IDA) |
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
4 | P01315 (/IDA) P01326 (/IDA) P01326 (/IDA) P01326 (/IDA) |
Negative regulation of lipid catabolic process GO:0050995
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Response to growth hormone GO:0060416
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Negative regulation of lactation GO:1903488
Any process that stops, prevents or reduces the frequency, rate or extent of lactation.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Positive regulation of lactation GO:1903489
Any process that activates or increases the frequency, rate or extent of lactation.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Positive regulation of blood circulation GO:1903524
Any process that activates or increases the frequency, rate or extent of blood circulation.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Response to butyrate GO:1903544
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a butyrate stimulus.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Response to L-arginine GO:1903576
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a L-arginine stimulus.
|
4 | A5PJB2 (/IDA) I7CLV3 (/IDA) I7CLV3 (/IDA) P01317 (/IDA) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
3 | P01326 (/IDA) P01326 (/IDA) P01326 (/IDA) |
Activation of MAPK activity GO:0000187
The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
|
3 | P01326 (/IDA) P01326 (/IDA) P01326 (/IDA) |
Negative regulation of acute inflammatory response GO:0002674
Any process that stops, prevents, or reduces the frequency, rate, or extent of an acute inflammatory response.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Negative regulation of acute inflammatory response GO:0002674
Any process that stops, prevents, or reduces the frequency, rate, or extent of an acute inflammatory response.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Glucose metabolic process GO:0006006
The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.
|
3 | P01326 (/IMP) P01326 (/IMP) P01326 (/IMP) |
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
|
3 | P01308 (/NAS) P01308 (/NAS) P01308 (/NAS) |
Regulation of cellular amino acid metabolic process GO:0006521
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving amino acids.
|
3 | P01308 (/IMP) P01308 (/IMP) P01308 (/IMP) |
Regulation of cellular amino acid metabolic process GO:0006521
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving amino acids.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Endoplasmic reticulum to Golgi vesicle-mediated transport GO:0006888
The directed movement of substances from the endoplasmic reticulum (ER) to the Golgi, mediated by COP II vesicles. Small COP II coated vesicles form from the ER and then fuse directly with the cis-Golgi. Larger structures are transported along microtubules to the cis-Golgi.
|
3 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) |
Acute-phase response GO:0006953
An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Acute-phase response GO:0006953
An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
ER overload response GO:0006983
The series of molecular signals generated by the accumulation of normal or misfolded proteins in the endoplasmic reticulum and leading to activation of transcription by NF-kappaB.
|
3 | P01326 (/IMP) P01326 (/IMP) P01326 (/IMP) |
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Cell-cell signaling GO:0007267
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
|
3 | P01308 (/IC) P01308 (/IC) P01308 (/IC) |
Myoblast fusion GO:0007520
A process in which non-proliferating myoblasts fuse to existing fibers or to myotubes to form new fibers. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
3 | P01326 (/IGI) P01326 (/IGI) P01326 (/IGI) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Insulin receptor signaling pathway GO:0008286
The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Insulin receptor signaling pathway GO:0008286
The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.
|
3 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
3 | P01326 (/IDA) P01326 (/IDA) P01326 (/IDA) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
3 | P01317 (/IDA) P67970 (/IDA) P67970 (/IDA) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
3 | P01308 (/IGI) P01308 (/IGI) P01308 (/IGI) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Positive regulation of nitric oxide mediated signal transduction GO:0010750
Any process that increases the rate, frequency or extent of nitric oxide mediated signal transduction. Nitric oxide mediated signal transduction is a series of molecular signals mediated by the detection of nitric oxide (NO).
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Positive regulation of nitric oxide mediated signal transduction GO:0010750
Any process that increases the rate, frequency or extent of nitric oxide mediated signal transduction. Nitric oxide mediated signal transduction is a series of molecular signals mediated by the detection of nitric oxide (NO).
|
3 | P01308 (/IMP) P01308 (/IMP) P01308 (/IMP) |
Positive regulation of nitric oxide mediated signal transduction GO:0010750
Any process that increases the rate, frequency or extent of nitric oxide mediated signal transduction. Nitric oxide mediated signal transduction is a series of molecular signals mediated by the detection of nitric oxide (NO).
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Myotube differentiation GO:0014902
The process in which a relatively unspecialized cell acquires specialized features of a myotube cell. Myotube differentiation starts with myoblast fusion and the appearance of specific cell markers (this is the cell development step). Then individual myotubes can fuse to form bigger myotubes and start to contract. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse.
|
3 | P01326 (/IGI) P01326 (/IGI) P01326 (/IGI) |
Lipid catabolic process GO:0016042
The chemical reactions and pathways resulting in the breakdown of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
|
3 | P01326 (/IDA) P01326 (/IDA) P01326 (/IDA) |
Regulation of transmembrane transporter activity GO:0022898
Any process that modulates the frequency, rate or extent of transmembrane transporter activity.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Regulation of transmembrane transporter activity GO:0022898
Any process that modulates the frequency, rate or extent of transmembrane transporter activity.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
3 | P01308 (/NAS) P01308 (/NAS) P01308 (/NAS) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
3 | P01308 (/ISS) P01308 (/ISS) P01308 (/ISS) |
Positive regulation of protein autophosphorylation GO:0031954
Any process that activates or increases the frequency, rate or extent of the phosphorylation by a protein of one or more of its own residues.
|
3 | P01308 (/ISS) P01308 (/ISS) P01308 (/ISS) |
Activation of protein kinase B activity GO:0032148
Any process that initiates the activity of the inactive enzyme protein kinase B.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Activation of protein kinase B activity GO:0032148
Any process that initiates the activity of the inactive enzyme protein kinase B.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Positive regulation of cellular protein metabolic process GO:0032270
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.
|
3 | P01308 (/IMP) P01308 (/IMP) P01308 (/IMP) |
Positive regulation of cellular protein metabolic process GO:0032270
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Negative regulation of protein oligomerization GO:0032460
Any process that stops, prevents, or reduces the frequency, rate or extent of protein oligomerization.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Negative regulation of protein oligomerization GO:0032460
Any process that stops, prevents, or reduces the frequency, rate or extent of protein oligomerization.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Regulation of protein localization GO:0032880
Any process that modulates the frequency, rate or extent of any process in which a protein is transported to, or maintained in, a specific location.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Regulation of protein localization GO:0032880
Any process that modulates the frequency, rate or extent of any process in which a protein is transported to, or maintained in, a specific location.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Negative regulation of NAD(P)H oxidase activity GO:0033861
Any process that stops or reduces the activity of the enzyme NAD(P)H oxidase.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Negative regulation of NAD(P)H oxidase activity GO:0033861
Any process that stops or reduces the activity of the enzyme NAD(P)H oxidase.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Negative regulation of protein catabolic process GO:0042177
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Negative regulation of protein catabolic process GO:0042177
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Regulation of phosphorylation GO:0042325
Any process that modulates the frequency, rate or extent of addition of phosphate groups into a molecule.
|
3 | P01326 (/IDA) P01326 (/IDA) P01326 (/IDA) |
Glucose homeostasis GO:0042593
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Regulation of protein binding GO:0043393
Any process that modulates the frequency, rate or extent of protein binding.
|
3 | P01326 (/IDA) P01326 (/IDA) P01326 (/IDA) |
Positive regulation of MAPK cascade GO:0043410
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Positive regulation of MAPK cascade GO:0043410
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Positive regulation of phosphatidylinositol 3-kinase activity GO:0043552
Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity.
|
3 | P01326 (/IDA) P01326 (/IDA) P01326 (/IDA) |
Cellular protein metabolic process GO:0044267
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
|
3 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) |
Positive regulation of cell differentiation GO:0045597
Any process that activates or increases the frequency, rate or extent of cell differentiation.
|
3 | P01308 (/NAS) P01308 (/NAS) P01308 (/NAS) |
Negative regulation of gluconeogenesis GO:0045721
Any process that stops, prevents, or reduces the frequency, rate or extent of gluconeogenesis.
|
3 | P01308 (/NAS) P01308 (/NAS) P01308 (/NAS) |
Positive regulation of glycogen biosynthetic process GO:0045725
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Positive regulation of glycogen biosynthetic process GO:0045725
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Negative regulation of glycogen catabolic process GO:0045818
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of glycogen.
|
3 | P01308 (/IMP) P01308 (/IMP) P01308 (/IMP) |
Negative regulation of glycogen catabolic process GO:0045818
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of glycogen.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Positive regulation of glycolytic process GO:0045821
Any process that activates or increases the frequency, rate or extent of glycolysis.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Positive regulation of glycolytic process GO:0045821
Any process that activates or increases the frequency, rate or extent of glycolysis.
|
3 | P01308 (/IMP) P01308 (/IMP) P01308 (/IMP) |
Positive regulation of glycolytic process GO:0045821
Any process that activates or increases the frequency, rate or extent of glycolysis.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Positive regulation of mitotic nuclear division GO:0045840
Any process that activates or increases the frequency, rate or extent of mitosis.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Positive regulation of mitotic nuclear division GO:0045840
Any process that activates or increases the frequency, rate or extent of mitosis.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Negative regulation of proteolysis GO:0045861
Any process that stops, prevents, or reduces the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein.
|
3 | P01308 (/IMP) P01308 (/IMP) P01308 (/IMP) |
Negative regulation of proteolysis GO:0045861
Any process that stops, prevents, or reduces the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Negative regulation of fatty acid metabolic process GO:0045922
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving fatty acids.
|
3 | P01308 (/IMP) P01308 (/IMP) P01308 (/IMP) |
Negative regulation of fatty acid metabolic process GO:0045922
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving fatty acids.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Positive regulation of glucose import GO:0046326
Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Positive regulation of glucose import GO:0046326
Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
|
3 | P01308 (/IMP) P01308 (/IMP) P01308 (/IMP) |
Positive regulation of glucose import GO:0046326
Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Positive regulation of insulin receptor signaling pathway GO:0046628
Any process that increases the frequency, rate or extent of insulin receptor signaling.
|
3 | P01308 (/IMP) P01308 (/IMP) P01308 (/IMP) |
Positive regulation of insulin receptor signaling pathway GO:0046628
Any process that increases the frequency, rate or extent of insulin receptor signaling.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Alpha-beta T cell activation GO:0046631
The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Alpha-beta T cell activation GO:0046631
The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Positive regulation of lipid biosynthetic process GO:0046889
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of lipids.
|
3 | P01308 (/NAS) P01308 (/NAS) P01308 (/NAS) |
Regulation of synaptic plasticity GO:0048167
A process that modulates synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
|
3 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) |
Regulation of protein secretion GO:0050708
Any process that modulates the frequency, rate or extent of the controlled release of a protein from a cell.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Regulation of protein secretion GO:0050708
Any process that modulates the frequency, rate or extent of the controlled release of a protein from a cell.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Negative regulation of protein secretion GO:0050709
Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of a protein from a cell.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Positive regulation of cytokine secretion GO:0050715
Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Positive regulation of cytokine secretion GO:0050715
Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Cognition GO:0050890
The operation of the mind by which an organism becomes aware of objects of thought or perception; it includes the mental activities associated with thinking, learning, and memory.
|
3 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) |
Negative regulation of lipid catabolic process GO:0050995
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids.
|
3 | P01308 (/IMP) P01308 (/IMP) P01308 (/IMP) |
Negative regulation of lipid catabolic process GO:0050995
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Negative regulation of lipid catabolic process GO:0050995
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids.
|
3 | P01308 (/NAS) P01308 (/NAS) P01308 (/NAS) |
Positive regulation of nitric-oxide synthase activity GO:0051000
Any process that activates or increases the activity of the enzyme nitric-oxide synthase.
|
3 | P01308 (/NAS) P01308 (/NAS) P01308 (/NAS) |
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Fatty acid homeostasis GO:0055089
Any process involved in the maintenance of an internal steady state of fatty acid within an organism or cell.
|
3 | P01308 (/IMP) P01308 (/IMP) P01308 (/IMP) |
Fatty acid homeostasis GO:0055089
Any process involved in the maintenance of an internal steady state of fatty acid within an organism or cell.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
|
3 | P01326 (/IGI) P01326 (/IGI) P01326 (/IGI) |
Negative regulation of respiratory burst involved in inflammatory response GO:0060266
Any process that decreases the rate, frequency or extent of a phase of elevated metabolic activity, during which oxygen consumption increases made as a defense response ; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Negative regulation of respiratory burst involved in inflammatory response GO:0060266
Any process that decreases the rate, frequency or extent of a phase of elevated metabolic activity, during which oxygen consumption increases made as a defense response ; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Positive regulation of respiratory burst GO:0060267
Any process that increases the rate frequency or extent of a phase of elevated metabolic activity, during which oxygen consumption increases; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Positive regulation of respiratory burst GO:0060267
Any process that increases the rate frequency or extent of a phase of elevated metabolic activity, during which oxygen consumption increases; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress GO:0070059
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to a stimulus indicating endoplasmic reticulum (ER) stress, and ends when the execution phase of apoptosis is triggered. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
|
3 | P01326 (/IMP) P01326 (/IMP) P01326 (/IMP) |
Positive regulation of peptide hormone secretion GO:0090277
Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
|
3 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) |
Positive regulation of brown fat cell differentiation GO:0090336
Any process that increases the rate, frequency, or extent of brown fat cell differentiation. Brown fat cell differentiation is the process in which a relatively unspecialized cell acquires specialized features of a brown adipocyte, an animal connective tissue cell involved in adaptive thermogenesis. Brown adipocytes contain multiple small droplets of triglycerides and a high number of mitochondria.
|
3 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) |
Positive regulation of blood vessel diameter GO:0097755
Any process that increases the diameter of blood vessels.
|
3 | P01308 (/NAS) P01308 (/NAS) P01308 (/NAS) |
Negative regulation of blood vessel diameter GO:0097756
Any process that decreases the diameter of blood vessels.
|
3 | P01308 (/NAS) P01308 (/NAS) P01308 (/NAS) |
Positive regulation of protein localization to nucleus GO:1900182
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Positive regulation of protein localization to nucleus GO:1900182
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Positive regulation of long-term synaptic potentiation GO:1900273
Any process that activates or increases the frequency, rate or extent of long-term synaptic potentiation.
|
3 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) |
Negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway GO:1902176
Any process that stops, prevents or reduces the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway.
|
3 | P01308 (/NAS) P01308 (/NAS) P01308 (/NAS) |
Positive regulation of dendritic spine maintenance GO:1902952
Any process that activates or increases the frequency, rate or extent of dendritic spine maintenance.
|
3 | P01308 (/IGI) P01308 (/IGI) P01308 (/IGI) |
Positive regulation of dendritic spine maintenance GO:1902952
Any process that activates or increases the frequency, rate or extent of dendritic spine maintenance.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Regulation of protein localization to plasma membrane GO:1903076
Any process that modulates the frequency, rate or extent of protein localization to plasma membrane.
|
3 | P01308 (/IGI) P01308 (/IGI) P01308 (/IGI) |
Regulation of protein localization to plasma membrane GO:1903076
Any process that modulates the frequency, rate or extent of protein localization to plasma membrane.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Negative regulation of reactive oxygen species biosynthetic process GO:1903427
Any process that stops, prevents or reduces the frequency, rate or extent of reactive oxygen species biosynthetic process.
|
3 | P01308 (/IGI) P01308 (/IGI) P01308 (/IGI) |
Negative regulation of reactive oxygen species biosynthetic process GO:1903427
Any process that stops, prevents or reduces the frequency, rate or extent of reactive oxygen species biosynthetic process.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Neuron projection maintenance GO:1990535
The organization process that preserves a neuron projection in a stable functional or structural state. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
|
3 | P01308 (/IGI) P01308 (/IGI) P01308 (/IGI) |
Neuron projection maintenance GO:1990535
The organization process that preserves a neuron projection in a stable functional or structural state. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Negative regulation of feeding behavior GO:2000252
Any process that stops, prevents or reduces the frequency, rate or extent of feeding behavior.
|
3 | P01308 (/IDA) P01308 (/IDA) P01308 (/IDA) |
Negative regulation of feeding behavior GO:2000252
Any process that stops, prevents or reduces the frequency, rate or extent of feeding behavior.
|
3 | P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Type B pancreatic cell differentiation GO:0003309
The process in which relatively unspecialized cells acquire specialized structural and/or functional features of a type B pancreatic cell. A type B pancreatic cell is a cell located towards center of the islets of Langerhans that secretes insulin.
|
2 | O73727 (/IMP) O73727 (/IMP) |
Neural retina development GO:0003407
The progression of the neural retina over time from its initial formation to the mature structure. The neural retina is the part of the retina that contains neurons and photoreceptor cells.
|
2 | P67970 (/TAS) P67970 (/TAS) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
2 | P67970 (/IDA) P67970 (/IDA) |
Response to temperature stimulus GO:0009266
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temperature stimulus.
|
2 | A3RID6 (/IDA) A3RID7 (/IDA) |
Protein secretion GO:0009306
The controlled release of proteins from a cell.
|
2 | A5PJB2 (/IMP) P01317 (/IMP) |
Response to glucose GO:0009749
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
2 | O73727 (/IDA) O73727 (/IDA) |
Gene expression GO:0010467
The process in which a gene's sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P67970 (/IDA) P67970 (/IDA) |
Endocrine pancreas development GO:0031018
The process whose specific outcome is the progression of the endocrine pancreas over time, from its formation to the mature structure. The endocrine pancreas is made up of islet cells that produce insulin, glucagon and somatostatin.
|
2 | P01325 (/TAS) P01325 (/TAS) |
Response to starvation GO:0042594
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a starvation stimulus, deprivation of nourishment.
|
2 | A3RID6 (/IDA) A3RID7 (/IDA) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
2 | P67970 (/IDA) P67970 (/IDA) |
Positive regulation of pancreatic A cell differentiation GO:2000228
Any process that activates or increases the frequency, rate or extent of pancreatic A cell differentiation.
|
2 | O73727 (/IMP) O73727 (/IMP) |
Negative regulation of feeding behavior GO:2000252
Any process that stops, prevents or reduces the frequency, rate or extent of feeding behavior.
|
2 | O73727 (/IMP) O73727 (/IMP) |
Lipid biosynthetic process GO:0008610
The chemical reactions and pathways resulting in the formation of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
|
1 | P01315 (/IMP) |
Glycoprotein biosynthetic process GO:0009101
The chemical reactions and pathways resulting in the formation of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.
|
1 | P01315 (/IMP) |
Response to glucose GO:0009749
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
1 | P01317 (/IMP) |
Response to organic substance GO:0010033
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
1 | P01322 (/IEP) |
Lactate biosynthetic process GO:0019249
The chemical reactions and pathways resulting in the formation of lactate, the anion of lactic acid.
|
1 | P01315 (/IMP) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
1 | P01315 (/IMP) |
Positive regulation of protein autophosphorylation GO:0031954
Any process that activates or increases the frequency, rate or extent of the phosphorylation by a protein of one or more of its own residues.
|
1 | P01315 (/IDA) |
Response to cytokine GO:0034097
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
|
1 | P01322 (/IEP) |
Positive regulation of Rho protein signal transduction GO:0035025
Any process that activates or increases the frequency, rate or extent of Rho protein signal transduction.
|
1 | P01317 (/IDA) |
Lipoprotein biosynthetic process GO:0042158
The chemical reactions and pathways resulting in the formation of any conjugated, water-soluble protein in which the covalently attached nonprotein group consists of a lipid or lipids.
|
1 | P01315 (/IMP) |
Response to peptide hormone GO:0043434
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.
|
1 | P01322 (/IEP) |
Negative regulation of gluconeogenesis GO:0045721
Any process that stops, prevents, or reduces the frequency, rate or extent of gluconeogenesis.
|
1 | P01315 (/IMP) |
Positive regulation of DNA replication GO:0045740
Any process that activates or increases the frequency, rate or extent of DNA replication.
|
1 | P01315 (/IDA) |
Response to cAMP GO:0051591
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
|
1 | P01322 (/IEP) |
Positive regulation of peptide hormone secretion GO:0090277
Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
|
1 | P01317 (/IDA) |
Positive regulation of cell maturation GO:1903431
Any process that activates or increases the frequency, rate or extent of cell maturation.
|
1 | P01317 (/IDA) |
Cellular response to palmitoleic acid GO:1904927
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a palmitoleic acid stimulus.
|
1 | P01318 (/IDA) |
There are 20 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
14 |
A3RID6 (/IDA)
A3RID7 (/IDA)
A5PJB2 (/IDA)
I7CLV3 (/IDA)
I7CLV3 (/IDA)
P01308 (/IDA)
P01308 (/IDA)
P01308 (/IDA)
P01317 (/IDA)
P01318 (/IDA)
(4 more) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
8 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) P01325 (/TAS) P01325 (/TAS) P01326 (/TAS) P01326 (/TAS) P01326 (/TAS) |
Secretory granule lumen GO:0034774
The volume enclosed by the membrane of a secretory granule.
|
8 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) P01325 (/TAS) P01325 (/TAS) P01326 (/TAS) P01326 (/TAS) P01326 (/TAS) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
6 | L5LRB0 (/ISS) L5LRB0 (/ISS) P01315 (/ISS) P01318 (/ISS) Q25C78 (/ISS) Q25C78 (/ISS) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
5 | P01325 (/ISO) P01325 (/ISO) P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
5 | P01325 (/IDA) P01325 (/IDA) P01326 (/IDA) P01326 (/IDA) P01326 (/IDA) |
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
|
5 | P01322 (/IDA) P01323 (/IDA) P01326 (/IDA) P01326 (/IDA) P01326 (/IDA) |
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
|
5 | P01325 (/ISO) P01325 (/ISO) P01326 (/ISO) P01326 (/ISO) P01326 (/ISO) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
5 | P01325 (/HDA) P01325 (/HDA) P01326 (/HDA) P01326 (/HDA) P01326 (/HDA) |
Golgi membrane GO:0000139
The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
|
3 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
3 | P01308 (/IC) P01308 (/IC) P01308 (/IC) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
3 | P01326 (/IDA) P01326 (/IDA) P01326 (/IDA) |
Small nucleolar ribonucleoprotein complex GO:0005732
A ribonucleoprotein complex that contains an RNA molecule of the small nucleolar RNA (snoRNA) family and associated proteins. Most are involved in a step of processing of rRNA: cleavage, 2'-O-methylation, or pseudouridylation. The majority, though not all, fall into one of two classes, box C/D type or box H/ACA type.
|
3 | P01326 (/IDA) P01326 (/IDA) P01326 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
3 | P01326 (/IDA) P01326 (/IDA) P01326 (/IDA) |
Endoplasmic reticulum lumen GO:0005788
The volume enclosed by the membranes of the endoplasmic reticulum.
|
3 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) |
Golgi lumen GO:0005796
The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.
|
3 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) |
Transport vesicle GO:0030133
Any of the vesicles of the constitutive secretory pathway, which carry cargo from the endoplasmic reticulum to the Golgi, between Golgi cisternae, from the Golgi to the ER (retrograde transport) or to destinations within or outside the cell.
|
3 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) |
Endosome lumen GO:0031904
The volume enclosed by the membrane of an endosome.
|
3 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) |
Endoplasmic reticulum-Golgi intermediate compartment membrane GO:0033116
The lipid bilayer surrounding any of the compartments of the endoplasmic reticulum (ER)-Golgi intermediate compartment system.
|
3 | P01308 (/TAS) P01308 (/TAS) P01308 (/TAS) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
2 | P01325 (/TAS) P01325 (/TAS) |